Alembic Pharmaceuticals Ltd Corporate Actions

Alembic Pharma Reports 17% Growth in Q4 Sales

 Copy Link

EBITDA was up 9% at ₹286 crore, with EBITDA margin at 16% of total sales, reflecting operating efficiency.

Alembic Pharma Gets USFDA Nod for Carbamazepine 200 mg

 Copy Link

The approved product is the generic equivalent of Tegretol Tablets 200 mg, which was initially developed by Novartis Pharmaceuticals Corporation.

Alembic Pharma Secures USFDA Approval for Pantoprazole Injection

 Copy Link

This approval bolsters Alembic's portfolio in the United States market and reinforces its presence in injectable segment 

Alembic Pharma’s Vadodara Plant Gets VAI Status from US FDA

 Copy Link

Following an inspection carried out from Nov 14-22 2024, the facility was cited as being ‘VAI’ (Voluntary Action Indicated).

Alembic Pharma reports 23% decline in Q3 net profit

 Copy Link

EBITDA margin came in at 15.4% in the quarter under review as compared to 16.30% in the previous corresponding period.

Alembic Pharma gets USFDA approval for generic heart failure medication

 Copy Link

The authorised ANDA is a therapeutic equivalent of the reference-listed drug (RLD), Corlanor tablets, in the same 5 mg and 7.5 mg dosages.

Alembic Pharma gets USFDA approval hypertension drug

 Copy Link

These medications are also used to treat chronic stable angina and angina induced by coronary artery spasm.

Alembic Pharma Gets USFDA Approval for Diltiazem ER Capsules

 Copy Link

Alembic Pharmaceuticals continues to grow its footprint in the US, with this approval contributing to its robust portfolio of generic medications.

Alembic Pharma's Gujarat plant clears USFDA inspection

 Copy Link

The business stated that the authorised ANDA is therapeutically similar to the reference-listed drug product (RLD) Lastacaft Solution.

Alembic Pharma Shares Jump on USFDA Approval for Lamotrigine Tablets

 Copy Link

The approved Lamotrigine Extended-Release tablets are therapeutic equivalents of GlaxoSmithKline's Lamictal XR, with strengths of 200 mg, 250 mg, and 300 mg.